Cho-Hao Line et al. reported that a bivalent BRD4 inhibitor, AZD5153, was able to inhibit the expression of pro-carcinogenic genes associated with BRD4, inhibit the proliferation of hepatocellular carcinoma cells and promote their apoptosis [225]. The gene discussed is BRD4; the disease is hepatocellular carcinoma.